Market revenue in 2023 | USD 136.6 million |
Market revenue in 2030 | USD 233.7 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Anti- inflammatories |
Fastest growing segment | Combination therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti- inflammatories, Bronchodilators, Combination therapy |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, GSK PLC, Merck & Co Inc, Roche Holding AG, AstraZeneca PLC, Boehringer Ingelheim, Sanofi SA, Koninklijke Philips NV, BD, Corvus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to asthma therapeutics market will help companies and investors design strategic landscapes.
Anti- inflammatories was the largest segment with a revenue share of 62.3% in 2023. Horizon Databook has segmented the UAE asthma therapeutics market based on anti- inflammatories, bronchodilators, combination therapy covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE’s asthma therapeutics market is anticipated to witness significant growth over the forecast period due to the increasing number of strategic initiatives undertaken by local players and favorable government initiatives.
Campaigns such as the Chronic Respiratory Diseases Awareness Program strive to improve early diagnosis rates and management of Chronic Respiratory Diseases at community and Primary Health Care (PHC) levels in the UAE.
Furthermore, due to a lack of standardized techniques to diagnose COPD, low public awareness, the indifferent attitude among the general public & physicians, and high incidence of smoking & environmental pollution, asthma is largely misdiagnosed/underdiagnosed.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE asthma therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into UAE asthma therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account